The infusion of toll-like receptor 9 (TLR9) agonist-activated macrophages exaggerated disease progression in doxorubicin-induced nephropathy in mice, whereas resting macrophages did not induce disease progression (Wang et al., 2008). The gene discussed is TLR9; the disease is Nephropathy.